YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes - PubMed (original) (raw)
. 2012 Dec 6;31(49):5117-22.
doi: 10.1038/onc.2012.5. Epub 2012 Jan 30.
Affiliations
- PMID: 22286761
- DOI: 10.1038/onc.2012.5
YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes
T Mizuno et al. Oncogene. 2012.
Abstract
Malignant mesothelioma (MM) shows frequent inactivation of the neurofibromatosis type 2 (NF2) -tumor-suppressor gene. Recent studies have documented that the Hippo signaling pathway, a downstream cascade of Merlin (a product of NF2), has a key role in organ size control and carcinogenesis by regulating cell proliferation and apoptosis. We previously reported that MMs show overexpression of Yes-associated protein (YAP) transcriptional coactivator, the main downstream effector of the Hippo signaling pathway, which results from the inactivation of NF2, LATS2 and/or SAV1 genes (the latter two encoding core components of the mammalian Hippo pathway) or amplification of YAP itself. However, the detailed roles of YAP remain unclear, especially the target genes of YAP that enhance MM cell growth and survival. Here, we demonstrated that YAP-knockdown inhibited cell motility, invasion and anchorage-independent growth as well as cell proliferation of MM cells in vitro. We analyzed genes commonly regulated by YAP in three MM cell lines with constitutive YAP-activation, and found that the major subsets of YAP-upregulating genes encode cell cycle regulators. Among them, YAP directly induced the transcription of CCND1 and FOXM1, in cooperation with TEAD transcription factor. We also found that knockdown of CCND1 and FOXM1 suppressed MM cell proliferation, although the inhibitory effects were less evident than those of YAP knockdown. These results indicate that constitutive YAP activation in MM cells promotes cell cycle progression giving more aggressive phenotypes to MM cells.
Similar articles
- LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade.
Tanaka I, Osada H, Fujii M, Fukatsu A, Hida T, Horio Y, Kondo Y, Sato A, Hasegawa Y, Tsujimura T, Sekido Y. Tanaka I, et al. Oncogene. 2015 Jan 2;34(1):73-83. doi: 10.1038/onc.2013.528. Epub 2013 Dec 16. Oncogene. 2015. PMID: 24336325 - Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
Tanaka K, Osada H, Murakami-Tonami Y, Horio Y, Hida T, Sekido Y. Tanaka K, et al. Cancer Lett. 2017 Jan 28;385:215-224. doi: 10.1016/j.canlet.2016.10.020. Epub 2016 Oct 20. Cancer Lett. 2017. PMID: 27773750 - LATS2 is a tumor suppressor gene of malignant mesothelioma.
Murakami H, Mizuno T, Taniguchi T, Fujii M, Ishiguro F, Fukui T, Akatsuka S, Horio Y, Hida T, Kondo Y, Toyokuni S, Osada H, Sekido Y. Murakami H, et al. Cancer Res. 2011 Feb 1;71(3):873-83. doi: 10.1158/0008-5472.CAN-10-2164. Epub 2011 Jan 18. Cancer Res. 2011. PMID: 21245096 - Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation.
Sekido Y. Sekido Y. Pathol Int. 2011 Jun;61(6):331-44. doi: 10.1111/j.1440-1827.2011.02666.x. Epub 2011 May 2. Pathol Int. 2011. PMID: 21615608 Review. - FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways.
Kelleher FC, O'Sullivan H. Kelleher FC, et al. Oncotarget. 2016 Jul 5;7(27):42792-42804. doi: 10.18632/oncotarget.8669. Oncotarget. 2016. PMID: 27074562 Free PMC article. Review.
Cited by
- A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression.
Li HL, Li QY, Jin MJ, Lu CF, Mu ZY, Xu WY, Song J, Zhang Y, Zhang SY. Li HL, et al. J Cancer Res Clin Oncol. 2021 Jun;147(6):1569-1585. doi: 10.1007/s00432-021-03604-8. Epub 2021 Apr 17. J Cancer Res Clin Oncol. 2021. PMID: 33864521 Review. - Rac1-Mediated DNA Damage and Inflammation Promote Nf2 Tumorigenesis but Also Limit Cell-Cycle Progression.
Shi Y, Bollam SR, White SM, Laughlin SZ, Graham GT, Wadhwa M, Chen H, Nguyen C, Vitte J, Giovannini M, Toretsky J, Yi C. Shi Y, et al. Dev Cell. 2016 Nov 21;39(4):452-465. doi: 10.1016/j.devcel.2016.09.027. Epub 2016 Nov 3. Dev Cell. 2016. PMID: 27818180 Free PMC article. - ASPP2 Is Phosphorylated by CDK1 during Mitosis and Required for Pancreatic Cancer Cell Proliferation.
Xiao Y, Chen Y, Chen J, Dong J. Xiao Y, et al. Cancers (Basel). 2023 Nov 15;15(22):5424. doi: 10.3390/cancers15225424. Cancers (Basel). 2023. PMID: 38001686 Free PMC article. - Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt Signaling.
Sementino E, Kadariya Y, Cheung M, Menges CW, Tan Y, Kukuyan AM, Shrestha U, Karchugina S, Cai KQ, Peri S, Duncan JS, Chernoff J, Testa JR. Sementino E, et al. Mol Cancer Res. 2022 May 4;20(5):699-711. doi: 10.1158/1541-7786.MCR-21-0837. Mol Cancer Res. 2022. PMID: 35082167 Free PMC article. - YAP/TAZ Activation as a Target for Treating Metastatic Cancer.
Warren JSA, Xiao Y, Lamar JM. Warren JSA, et al. Cancers (Basel). 2018 Apr 10;10(4):115. doi: 10.3390/cancers10040115. Cancers (Basel). 2018. PMID: 29642615 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous